Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates
- 2 March 1999
- journal article
- research article
- Published by Elsevier
- Vol. 102 (1-2) , 31-37
- https://doi.org/10.1016/0304-3835(96)04151-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mammalian l-amino acid decarboxylases producing 1,4-diamines: analogies among differencesTrends in Biochemical Sciences, 1994
- Expression of different mitogen‐regulated protein/proliferin mRNAs in Ehrlich carcinoma cellsFEBS Letters, 1994
- Vinca alkaloids enhance the half-life of tumour ornithine decarboxylaseCancer Letters, 1994
- Didemnin B in metastatic malignant melanomaAnti-Cancer Drugs, 1994
- Chlorpheniramine inhibits the ornithine decarboxylase induction of Ehrlich carcinoma growing in vivoFEBS Letters, 1992
- Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogsJournal of Medicinal Chemistry, 1991
- Phase I clinical and pharmacokinetic investigation of didemnin B, a cyclic depsipeptideEuropean Journal of Cancer and Clinical Oncology, 1988
- Didemnin B inhibits biological effects of tumor promoting phorbol esters on mouse skin, as well as phosphorylation of a 100 kD protein in mouse epidermis cytosolCancer Letters, 1987
- Mechanism of action of didemnin B, a depsipeptide from the seaCancer Letters, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976